Determinants of relapse risk under disease-modifying therapies in multiple sclerosis: an Andersen-Gill Cox regression analysis.

Fecha de publicación: 01/10/2026 Fecha Ahead of Print: 31/07/2026

Autores de IIS La Fe

Athanasios Pouptsis

Autor

Participantes ajenos a IIS La Fe

Pastor LB
Rojo JM

Grupos

Unidad de Biomarcadores y Medicina de Precisión (UBYMP)

Abstract

This observational, analytical, and retrospective individual-level study utilizes real-world data to generate evidence. We analyzed a cohort of 228 patients with multiple sclerosis from Valencia, who were monitored for up to 27 years. Our study assessed relapse-free survival rates across six different disease-modifying therapies and identified risk factors for relapse using Cox proportional hazards models.

Datos de la publicación

ISSN/ISSNe:: 2211-0348, 2211-0356
Tipo:: Article
Páginas:: 107418-107418
DOI:: 10.1016/j.msard.2026.107418
PubMed:: 42567026
Factor de Impacto:: 1,006 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Keywords

Cox regression; Disease-modifying therapies; Multiple sclerosis; Relapse; Survival analysis

Cita

Cita Bibliográfica